Patent Assignment
Reel/Frame 063985/0868
Assignment of Assignor's Interest
Recorded: 2023-06-19
Pages: 4
Assignor
SPITFIRE PHARMA LLC
Executed: 2019-07-12
Assignee
MEDERIS DIABETES, LLC
7515 GUINEVERE DR, SUGAR LAND, TEXAS, 77479
Covered Properties
(3)
Improved Peptide Pharmaceuticals for Treatment of Nash and Other Disorders
PCT:
PCT/US2019/012194 ↗
Peptide Pharmaceuticals for Treatment of Nash and Other Disorders
Peptide Pharmaceuticals for Treatment of NASH
Application:
62/613,396 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2018
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044744/0075 →
Assignment of Assignor's Interest
Jul 20, 2019
From: SPITFIRE PHARMA INC.
To: MEDERIS DIABETES INC.
Reel/Frame 049809/0939 →
Assignment of Assignor's Interest
Feb 17, 2025
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 070240/0338 →
Affidavit of Address Change
Feb 17, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070240/0403 →
Security Interest
May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →